Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis
Open Access
- 7 November 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1499
- https://doi.org/10.3389/fimmu.2017.01499
Abstract
Tuberculosis (TB) continues to be a devastating infectious disease and remerges as a global health emergency due to an alarming rise of antimicrobial resistance to its treatment. Despite of the serious effort that has been applied to develop effective anti-tubercular chemotherapies, the potential of antimicrobial peptides (AMPs) remains underexploited. A large amount of literature is now accessible on the AMP mechanisms of action against a diversity of pathogens; nevertheless, research on their activity on mycobacteria is still scarce. In particular, there is an urgent need to integrate all available interdisciplinary strategies to eradicate extensively drug resistant Mycobacterium tuberculosis strains. In this context, we should not underestimate our endogenous antimicrobial proteins and peptides as ancient players of the human host defence system. We are confident that novel antibiotics based on human AMPs displaying a rapid and multifaceted mechanism, with reduced toxicity, should significantly contribute to reverse the tide of anti-mycobacterial drug resistance. In this review, we have provided an up to date perspective of the current research on AMPs to be applied in the fight against TB. A better understanding on the mechanisms of action of human endogenous peptides should ensure the basis for the best guided design of novel antitubercular chemotherapeutics.Keywords
Funding Information
- Ministerio de Economía y Competitividad (SAF2015-66007P)
This publication has 161 references indexed in Scilit:
- Conformational Flexibility Determines Selectivity and Antibacterial, Antiplasmodial, and Anticancer Potency of Cationic α-Helical Peptides*Journal of Biological Chemistry, 2012
- Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathologyTuberculosis, 2011
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux MechanismCell, 2011
- Describing the Mechanism of Antimicrobial Peptide Action with the Interfacial Activity ModelACS Chemical Biology, 2010
- Hepcidin messenger RNA expression in human lymphocytesImmunology, 2010
- Induction of group A Streptococcus virulence by a human antimicrobial peptideProceedings of the National Academy of Sciences, 2008
- Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2–MyD88 signal pathway in dendritic cells and enhances Th2 immune responsesThe Journal of Experimental Medicine, 2008
- Lysosomal killing ofMycobacteriummediated by ubiquitin-derived peptides is enhanced by autophagyProceedings of the National Academy of Sciences, 2007
- Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytesMedical Microbiology and Immunology, 2007
- Neutrophil serine proteases: specific regulators of inflammationNature Reviews Immunology, 2006